| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.29B | 33.33B | 30.65B | 28.24B | 25.64B | 22.82B |
| Gross Profit | 12.68B | 13.05B | 11.86B | 10.72B | 10.15B | 9.31B |
| EBITDA | 9.30B | 9.44B | 8.79B | 7.65B | 7.44B | 6.62B |
| Net Income | 4.70B | 6.53B | 5.99B | 5.20B | 4.99B | 4.38B |
Balance Sheet | ||||||
| Total Assets | 31.79B | 34.49B | 31.44B | 31.63B | 33.01B | 30.93B |
| Cash, Cash Equivalents and Short-Term Investments | 15.05B | 15.36B | 12.05B | 13.20B | 17.44B | 14.78B |
| Total Debt | 598.02M | 285.01M | 301.81M | 305.77M | 305.77M | 310.84M |
| Total Liabilities | 6.82B | 8.71B | 6.45B | 5.90B | 5.31B | 5.22B |
| Stockholders Equity | 24.96B | 25.77B | 24.99B | 25.73B | 27.70B | 25.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 7.17B | 6.16B | 5.03B | 4.95B | 5.15B |
| Operating Cash Flow | 0.00 | 7.91B | 7.03B | 5.53B | 5.00B | 5.21B |
| Investing Cash Flow | 0.00 | 1.97B | -2.61B | -2.29B | 348.35M | -219.77M |
| Financing Cash Flow | 0.00 | -6.86B | -6.97B | -7.39B | -3.00B | -2.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥789.78B | 14.50 | ― | 1.30% | 27.81% | 23.24% | |
72 Outperform | ¥108.02B | 6.70 | ― | 3.44% | 8.76% | 11.13% | |
72 Outperform | ¥24.33B | 16.33 | ― | 3.50% | 12.08% | 16.50% | |
71 Outperform | ¥22.21B | 8.70 | ― | 2.18% | ― | ― | |
64 Neutral | ¥30.97B | 31.60 | ― | 4.39% | 7.87% | -23.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥58.49B | -15.07 | ― | 2.96% | 10.85% | -55.42% |